Rectal carcinoma: Is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication;Rektumkarzinom: Behandeln wir zu häufig neoadjuvant? Vorschläge zu einer selektiveren, MRT-basierten indikation

Zentralblatt fur Chirurgie

Volumn 131, Issue 4, 2006, Pages 275-284

  Junginger, Th ^a,c   Hermanek, P ^b   Oberholzer, K ^a   Schmidberger, H ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Magnetic resonance imaging; Mesorectal excision; Multimodal treatment; Neoadjuvant long course radiochemotherapy; Rectal carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ARTICLE; CANCER RECURRENCE; HUMAN; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; RECTUM CARCINOMA; RECTUM SURGERY; RECTUM TUMOR;

COMBINED MODALITY THERAPY; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; META-ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE CARE; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; RECTUM; RISK FACTORS; TIME FACTORS;

EID: 33748789596     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-946549     Document Type: Article

References (0)